ODAC 30% Off Registration, Use Code: JDD30
Skip to main content
JDD in the Media

Why Melatonin Is Really Good for Your Skin

By April 29, 2020No Comments

Dermatology News

Featured Article

Melatonin is one of the latest trendy skincare ingredients that supposedly helps restore and improve skin tone, while helping to combat signs of aging.
While the hormone helps improve the body’s sleep and wake cycle, there has been evidence that it furnishes antioxidant properties that rival that of vitamin C and E.
Read Article Now

"Why Melatonin Is Really Good for Your Skin"

Melatonin is one of the latest trendy skincare ingredients that supposedly helps restore and improve skin tone, while helping to combat signs of aging.
While the hormone helps improve the body’s sleep and wake cycle, there has been evidence that it furnishes antioxidant properties that rival that of vitamin C and E.

Elle Magazine’s recent feature, “Why Melatonin Is Really Good for Your Skin” cites JDD research on the matter, “Assessing the Potential Role for Topical Melatonin as an Antiaging Skin Regimine.”

All day long, your skin encounters damaging free radicals, thanks to pollution and UV exposure. These face foes can alter the skin’s DNA, resulting in photo damage and even cancer, according to Lain. In order to neutralize free radicals, your body makes antioxidants, with the help of antioxidant enzymes. “Melatonin stimulates your body’s natural production of these enzymes,” says Dr Engelman. And, according to a study published in the Journal of Drugs in Dermatology, these melatonin-induced antioxidants are more effective than those from the ever-popular vitamins C and E.

Melatonin works in concert with more common anti-aging ingredients to increase antioxidant levels, and dermal applications don’t seem to affect energy levels.

Learn more about Melatonin’s use in anti-aging skin regimens – check out the article here.

Read Article Now
JDD Article Referenced in this Post

You May Also Like

Featured ArticlesHidradenitis SuppurativaJDD in the MediaLatest NewsHot Topics in the JDD: Hidradenitis Suppurativa
October 27, 2026

Hot Topics in the JDD: Hidradenitis Suppurativa

Hidradenitis suppurativa (HS) treatment has drastically changed in the last 15 years with FDA-approved biologics and an understanding of the need for comprehensive care that addresses the multifactorial pathogenesis of…
Journal of Drugs in Dermatology JDD featuring Injectable NASHA Gel Skinbooster for Facial Skin Aging in Premenopausal and Postmenopausal Women With Estrogen Deficiency-Associated Not Receiving Hormone Therapy: A Case SeriesAestheticsFeatured ArticlesLatest NewsWomenInjectable NASHA Gel Skinbooster for Facial Skin Aging in Premenopausal and Postmenopausal Women With Estrogen Deficiency-Associated Not Receiving Hormone Therapy: A Case Series
October 26, 2026

Injectable NASHA Gel Skinbooster for Facial Skin Aging in Premenopausal and Postmenopausal Women With Estrogen Deficiency-Associated Not Receiving Hormone Therapy: A Case Series

Addressing Estrogen Deficiency Skin Aging: A Non-Hormonal Approach  Here is an insightful new study featured in the JDD! Intrinsic skin aging associated with estrogen deficiency presents a distinct therapeutic challenge…
Journal of Drugs in Dermatology JDD featuring Off-Label Uses of Nemolizumab: A Narrative ReviewAtopic DermatitisFeatured ArticlesLatest NewsOff-Label Uses of Nemolizumab: A Narrative Review
October 23, 2026

Off-Label Uses of Nemolizumab: A Narrative Review

Beyond AD and PN: Expanding Horizons for Interleukin-31 Blockade in Treatment-Refractory Pruritus  Have you read this article from the JDD? Interleukin-31 receptor alpha targeting has established its place in our…

Leave a Reply